Artículo | 2024 |
CD59 gene: 143 haplotypes of 22,718 nucleotides length by computational phasing in 113 individuals from different ethnicities
|
TRANSFUSION |
Artículo | 2024 |
DNA Reference Reagents for Genotyping RH Variants
|
Journal of Molecular Diagnostics |
Editorial | 2024 |
RH alleles: historical milestones, molecular advances, and clinical application
|
Annals of Blood |
Artículo | 2023 |
Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial
|
EClinicalMedicine |
Artículo | 2023 |
Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy
|
BIOMEDICINE & PHARMACOTHERAPY |
Artículo | 2023 |
Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
Artículo | 2022 |
High efficacy of Glecaprevir/Pibrentasvir for HCV-Infected individuals with active drug use.
|
JOURNAL OF INFECTION |
Artículo | 2021 |
Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic?
|
INTERNATIONAL JOURNAL OF STD & AIDS |
Artículo | 2021 |
HIV infection is associated with lower risk of hepatocellular carcinoma after sustained virological response to direct-acting antivirals in hepatitis C infected-patients with advanced fibrosis
|
CLINICAL INFECTIOUS DISEASES |
Artículo | 2021 |
Kinetics of emergence of liver complications in HCV-infected patients and advanced fibrosis, with and without HIV-coinfection, after SVR.
|
AIDS |
Artículo | 2021 |
Liver manifestations in COVID-19 and the influence of pre-existing liver disease in the course of the infection
|
Revista Española de Enfermedades Digestivas |
Artículo | 2021 |
Liver stiffness-based strategies predict absence of variceal bleeding in cirrhotic hepatitis C virus-infected patients with and without human immunodeficiency virus coinfection after sustained virological response
|
CLINICAL INFECTIOUS DISEASES |
Artículo | 2021 |
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
|
CLINICAL MICROBIOLOGY AND INFECTION |
Artículo | 2021 |
Valoración de secuelas clínica, radiológicas y funcionales en pacientes supervivientes de neumonía por SARS-CoV-2
|
ATENCION PRIMARIA |
Letter | 2020 |
High risk of hepatitis B virus reactivation among patients treated with direct-acting antivirals and coinfected with HCV and HIV
|
JOURNAL OF INFECTION |
Artículo | 2020 |
Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients
|
AIDS |
Artículo | 2020 |
Liver stiffness at the time of sustained virological response predicts the clinical outcome in people living with human immunodeficiency virus and hepatitis C virus with advanced fibrosis treated with direct-acting antivirals
|
CLINICAL INFECTIOUS DISEASES |
Artículo | 2020 |
Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease
|
CLINICAL INFECTIOUS DISEASES |
Artículo | 2020 |
Profile of new HIV diagnoses and risk factors associated with late diagnosis in a specialized outpatient clinic during the 2014-2018 period
|
MEDICINA CLINICA |
Artículo | 2019 |
Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: A preliminary
|
BMC INFECTIOUS DISEASES |
Artículo | 2019 |
High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world
|
JOURNAL OF HEPATOLOGY |
Artículo | 2019 |
HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals
|
AIDS |
Artículo | 2019 |
Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients
|
AIDS |
Artículo | 2019 |
Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort
|
PLOS ONE |
Artículo | 2019 |
Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy
|
JOURNAL OF HEPATOLOGY |
Artículo | 2019 |
Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain
|
AIDS |
Artículo | 2018 |
Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life
|
Scientific reports |
Artículo | 2018 |
Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients
|
AIDS |
Artículo | 2018 |
High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial
|
PLOS ONE |
Artículo | 2018 |
Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort
|
JOURNAL OF VIRAL HEPATITIS |
Artículo | 2018 |
Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice
|
HIV CLINICAL TRIALS |
Artículo | 2018 |
Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
Letter | 2017 |
Hepatitis aguda fulminante por virus B durante el tratamiento del virus de la hepatitis C con antivirales de acción directa en paciente infectado con VIH
|
Enfermedades infecciosas y microbiología clínica |
Artículo | 2017 |
HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study
|
HIV CLINICAL TRIALS |
Artículo | 2017 |
Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis
|
AIDS |
Artículo | 2017 |
Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection
|
CLINICAL MICROBIOLOGY AND INFECTION |
Artículo | 2016 |
Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens
|
PLOS ONE |
Artículo | 2016 |
Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study
|
PLOS ONE |
Artículo | 2016 |
Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort
|
PLOS ONE |
Artículo | 2016 |
No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014
|
BMC INFECTIOUS DISEASES |
Artículo | 2015 |
Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
Artículo | 2015 |
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
Artículo | 2015 |
Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection
|
PLOS ONE |
Artículo | 2015 |
Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis
|
BMC INFECTIOUS DISEASES |
Artículo | 2013 |
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/Hepatitis C virus-coinfected patients with compensated cirrhosis
|
CLINICAL INFECTIOUS DISEASES |
Artículo | 2013 |
Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain
|
CLINICAL INFECTIOUS DISEASES |
Artículo | 2013 |
Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients
|
AIDS |
Artículo | 2012 |
Comparison of High Ribavirin Induction Versus Standard Ribavirin Dosing, Plus Peginterferon-alpha for the Treatment of Chronic Hepatitis C in HIV-Infected Patients: The PERICO Trial
|
JOURNAL OF INFECTIOUS DISEASES |
Artículo | 2012 |
Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients
|
AIDS |
Letter | 2012 |
Liver stiffness correlates with Child-Pugh-Turcotte and MELD scores in HIV/hepatitis C virus-coinfected patients with cirrhosis
|
LIVER INTERNATIONAL |
Artículo | 2012 |
Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis
|
HEPATOLOGY |
Artículo | 2012 |
Long-term outcome of patients after a single interruption of antiretroviral therapy: a cohort study.
|
BMC HEALTH SERVICES RESEARCH |
Artículo | 2012 |
Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus-Coinfected Patients With Compensated Liver Cirrhosis
|
CLINICAL INFECTIOUS DISEASES |
Artículo | 2012 |
Tunneled hemodialysis catheter-related bloodstream infections: a prospective multicenter cohort study from Spain
|
JOURNAL OF VASCULAR ACCESS |
Artículo | 2011 |
Liver toxicity of antiretroviral combinations including Fosamprenavir plus Ritonavir 1400/100mg once daily in HIV/Hepatitis C virus-coinfected patients
|
AIDS Patient Care and ST Ds |
Ponencia | 2010 |
BACTERIEMIA POR STAPHYLOCOCCUS AUREUS: FACTORES PRONÓSTICOS GLOBALES
|
Enfermedades infecciosas y microbiología clínica |
Artículo | 2010 |
Nevirapine-based antiretroviral therapy is associated with lower plasma hepatitis C virus viral load among HIV/ hepatitis C Virus-Coinfected patients
|
Journal of AIDS and Clinical Research |
Letter | 2010 |
Rapid Improvement in Fasting Lipids and Hepatic Toxicity After Switching From Didanosine/Lamivudine to Tenofovir/Emtricitabine in Patients With Toxicity Attributable to Didanosine
|
HIV CLINICAL TRIALS |
Artículo | 2009 |
EFFECTIVENESS AND SAFETY OF SOMPLIFICATION FROM TENOFOVIR-LAMIVIDINE (TDF-3TC) TO TENOFOVIR-EMTRICITABINE (TDF-FTC) CO-FORMULATION (TRUVADA) IN VIROLOGICALLY SUPPRESSED HIV-INFECTED PATIENTS ON HAART.
|
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES |
Artículo | 2009 |
Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus-Coinfected Patients with Advanced Immunosuppression
|
CLINICAL INFECTIOUS DISEASES |
Ponencia | 2009 |
ESTUDIO DESCRIPTIVO DE PACIENTES VIH MULTIRRESISTENTES EN SEGUIMIENTO EN EL HOSPITAL VIRGEN MACARENA.
|
Enfermedades infecciosas y microbiología clínica |
Ponencia | 2009 |
EVOLUCIÓN DE LAS TASAS DE RESISTENCIA A FÁRMACOS ANTIRRETROVIRALES EN PACIENTES INFECTADOS POR EL VIH-1 EN FRACASO VIROLÓGICO
|
Enfermedades infecciosas y microbiología clínica |
Artículo | 2009 |
Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
Artículo | 2009 |
High seroprevalence but low incidence of HCV infection in a cohort of patients with sexually transmitted HIV in Andalusia, Spain
|
Journal of the International Association of Physicians in AIDS Care |
Artículo | 2009 |
Liver Stiffness as a Predictor of Esophageal Varices Requiring Therapy in HIV/Hepatitis C Virus-Coinfected Patients With Cirrhosis
|
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES |
Artículo | 2009 |
Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients
|
CLINICAL INFECTIOUS DISEASES |
Artículo | 2008 |
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome
|
ANTIVIRAL THERAPY |
Artículo | 2008 |
Antiretroviral-associated portal hypertension: A new clinical condition? Prevalence, predictors and outcome
|
ANTIVIRAL THERAPY |
Artículo | 2008 |
Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients
|
JOURNAL OF HEPATOLOGY |
Artículo | 2008 |
Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients
|
AIDS |
Artículo | 2008 |
Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
Artículo | 2008 |
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
Artículo | 2008 |
Long-term assessment of didanosine, lamivudine, and efavirenz in antiretroviral-naive patients: 3-year follow-up
|
AIDS RESEARCH AND HUMAN RETROVIRUSES |
Artículo | 2008 |
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era
|
AIDS RESEARCH AND HUMAN RETROVIRUSES |
Artículo | 2007 |
Clinical progression of hepatitis C virus - Related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active Antiretroviral therapy
|
HEPATOLOGY |
Artículo | 2007 |
IMPACT OF SYPHILIS INFECTION ON HIV VIRAL LOAD AND CD4 CELL COUNTS IN HIV-INFECTED PATIENTS
|
Journal of Acquired Immune Deficiency Syndromes |
Artículo | 2007 |
Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients
|
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY |
Artículo | 2007 |
Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients
|
ANTIVIRAL THERAPY |
Artículo | 2007 |
The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection
|
CLINICAL INFECTIOUS DISEASES |
Letter | 2006 |
Acute adverse effects following administration of liposomal amphotericin B [1]
|
Enfermedades infecciosas y microbiología clínica |
Artículo | 2006 |
Bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli in the CTX-M era: A new clinical challenge
|
CLINICAL INFECTIOUS DISEASES |
Ponencia | 2006 |
EPIDEMIOLOGÍA Y RELEVANCIA CLÍNICA DE LA BACTERIEMIA COMUNITARIA Y NOSOCOMIAL POR ESCHERICHIA COLI PRODUCTOR DE BETA-LACTAMASAS DE ESPECTRO EXTENDIDO (ECBLEE)
|
Enfermedades infecciosas y microbiología clínica |
Artículo | 2006 |
Severe liver disease associated with prolonged exposure to antiretroviral drugs
|
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES |
Letter | 2005 |
A case-control study of HIV patients with the K65R mutation in the reverse transcriptase gene with virological failure [2]
|
AIDS |
Ponencia | 2005 |
COMMUNITY-ACQUIRED BACTERAEMIA DUE TO EXTENDED-SPECTRUM BETA-LACTAMASE-PRODUCING ESCHERICHIA COLI: AN EMERGING CLINICAL CHALLENGE.
|
CLINICAL MICROBIOLOGY AND INFECTION |
Letter | 2005 |
Multiple cerebral ischemic infarcts as a complication of boutonneuse fever
|
Enfermedades infecciosas y microbiología clínica |
Artículo | 2005 |
Sam68 is tyrosine phosphorylated and recruited to signalling in peripheral blood mononuclear cells from HIV infected patients
|
CLINICAL AND EXPERIMENTAL IMMUNOLOGY |
Artículo | 2005 |
Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naive patients: The VESD study
|
HIV CLINICAL TRIALS |
Ponencia | 2004 |
ENDOCARDITIS ASOCIADA A MARCAPASOS Y DESFIBRILADORES
|
Enfermedades infecciosas y microbiología clínica |
Artículo | 2003 |
Bacteriemias por Acinetobacter baumannii: características clínicas y pronósticas
|
Enfermedades infecciosas y microbiología clínica |
Artículo | 2003 |
Factors associated with time to sputum smear conversion in active pulmonary tuberculosis
|
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE |
Artículo | 2003 |
SÍNDROME DE INFILTRACIÓN LINFOCITARIA DIFUSA EN PACIENTE CON INFECCIÓN POR VIRUS DE LA INMUNODEFICIENCIA HUMANA
|
Enfermedades infecciosas y microbiología clínica |
Letter | 2003 |
Visceral leishmaniasis and peritoneal tuberculosis in a patient with human immunodeficiency virus infection [3]
|
MEDICINA CLINICA |
Artículo | 2002 |
Corynebacterium macginleyi isolated from urine in a patient with a permanent bladder catheter
|
Scandinavian journal of infectious diseases |
Nota | 2002 |
Leishmaniasis aislada laríngea y cultivo de médula ósea
|
Enfermedades infecciosas y microbiología clínica |
Letter | 2001 |
Endocarditis tricuspídea por Prevotella denticola en un consumidor de drogas por vía parenteral
|
Enfermedades infecciosas y microbiología clínica |
Letter | 1999 |
The empty sella turcica syndrome associated with hypopituitarism
|
ANALES DE MEDICINA INTERNA |
Letter | 1998 |
Diabetes insipida nefrogenica secundaria a la administracion de anfotericina B y anfotericina B liposomal
|
Enfermedades infecciosas y microbiología clínica |
Letter | 1998 |
Kawasaki disease and parvovirus B19 infection in an adult HIV-1-infected patient
|
CLINICAL MICROBIOLOGY AND INFECTION |
Artículo | 1998 |
Tumoracion costal dolorosa en un paciente HIV positivo
|
Enfermedades infecciosas y microbiología clínica |
Artículo | 1998 |
Utilidad de la ecografia abdominal en el diagnostico de la tuberculosis extrapulmonar en pacientes infectados por el HIV
|
Enfermedades infecciosas y microbiología clínica |
Artículo | 1996 |
Análisis de series temporales en la epidemiología de la fiebre tifoidea en España
|
MEDICINA CLINICA |
Letter | 1993 |
Non-Hodgkin's lymphoma associated with rheumatoid arthritis
|
ANALES DE MEDICINA INTERNA |